TY  -  
T1  - Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women 
SN  -  /  
UR  - http://hdl.handle.net/10138/334845 
T3  -  
A1  - Keikkala, Elina; Forsten, Janina; Ritvos, Olli; Stenman, Ulf-Håkan; Kajantie, Eero; Hämäläinen, Esa; Räikkönen, Katri; Villa, Pia M.; Laivuori, Hannele 
A2  -  
PB  -  
Y1  - 2021 
LA  - eng 
AB  - Objectives: Maternal serum inhibin-A , pregnancy associated plasma protein-A (PAPP-A) and PAPP-A2 together with placental growth factor (PlGF), maternal risk factors and uterine arter y pulsatility inde x (UtA PI) were analysed to study thei r ability to predict pre-eclampsia (PE). Study design: Serial serum samples for the nested case-control study were collected prospectively at 12-14, 18-20 and 26-28 weeks of gestation from 11 women who later developed early-onset PE (EO PE , diagnosis < 34 +... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Pre-eclampsia; Prediction; Pregnancy; inhibin-A; pregnancy associated plasm a protein-A2; Placental growth factor; PLASMA-PROTEIN-A; LOW-DOSE ASPIRIN; EARLY-PREGNANCY; ACTIVIN-A; EXPRESSION; GESTATION; MARKERS; LOCALIZATION; ACID; 3123 Gynaecology and paediatrics; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -